Hanger Orthopedic Group, Inc. (HGR) rated Buy with price target $27 by Jefferies
Jefferies rated Buy Hanger Orthopedic Group, Inc. (NYSE: HGR) on 01/13/2011, when the stock price was $22.01. Since
then, Hanger Orthopedic Group, Inc. has gained 18.40% as of 03/19/2015's recent price of $26.06. If you would have followed this Jefferies's recommendation on HGR, you would have gained 18.4% of your investment in 1526 days.
Hanger Orthopedic Group Inc. owns and operates orthotic and prosthetic (O&P) patient-care centers in the United States. Hanger Orthopedic Group, through its wholly owned subsidiary, Southern Prosthetic Supply, Inc. (SPS), distributes branded and private label O&P devices and components in the United States, all of which are manufactured by third parties. The Company also creates new products, through its wholly owned subsidiary, Innovative Neurotronics, Inc. (IN Inc.) for patients who have had a loss of mobility due to strokes, multiple sclerosis or other similar conditions. In May 2009, the Company acquired Northwest Prosthetic & Orthotic Clinic and Inline Orthotic and Prosthetic Systems. In October 2009, Hanger Orthopedic Group Inc. acquired Creative Orthotics & Prosthetics, Inc., Custom Orthopedics of Wyoming and certain orthotics and prosthetics assets from the Hospital of the University of Pennsylvania.
s' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.